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a total of 474, 456, 443, 421, and 370 subjects completed the
1st, 2nd, 3rd, 4th, and 5th yr study, respectively. At the end
of each year, samples were analyzed from those subjects with
protocol-deﬁned HBV DNA breakthrough (increase ≥ 1.0 log10
copy/ml from the treatment nadir) for the rtN236T or rtA181V
ADV mutations associated with in vitro ADV resistance. ADV was
associated with a low rate of resistance, cumulative rate of 0%
after 1 year,1.3% after 2 years, 5.4% after 3 years and 10.4% after
4 years, 14.6% after 5 years.
Our data showed that treatment with ADV in Chinese HBeAg
positive CHB subjects for up to 5 years resulted in a cumulative
rate of 14.6% (70/480) ADV resistance-associated mutations with
HBV DNA breakthrough.
Concurrent Session 10 – Use and Abuse of Antibiotics
CS10-01 The Role of Infectious Disease Physician in the
Rational Use of Antibiotics
Yonghong Xiao*. First Hospital, Peking University, Beijing, China
Antibacterial agents are the most common used drug in daily clin-
ical practice, in which the wide application and high requirement
for professional capability often leads irrational prescription.
The professionals are urgent need for promoting antibiotic use.
Infectious disease physicians should take the key role in the work
because:
1. Infectious doctors holding professional priority:
a. One of the responsibilities endue with infectious doctor is
therapy of infections;
b. Antibiotic is the major therapeutic measure for infectious
doctor;
c. Infectious doctors are familiar with all the basic infor-
mation related with infection and chemotherapy, such as
bacteriology, virology and antibiotics;
d. Infectious doctors are in the center for contacting pharma-
cist, microbiologist and nosocomial infection controller.
2. Infectious doctors should do following effect to conduct the
work well:
a. Afﬂuent experience in diagnosis and treatment of infec-
tious diseases;
b. Substantial basic medical knowledge, such as epidemiol-
ogy, bacteriology, pathogenesis, pathology, etc;
c. Catching up with new information concerning with their
occupation, such as bacterial resistance, new antibacterial
therapeutic strategy, etc;
d. Familiar with all the information of antibacterial agents,
such as pharmacodynamics, pharmacokinetics, dosing, side
effect, indications, etc.
3. Infectious doctors should take the role by:
a. Collaboration with their clinical co-workers in other ﬁelds;
b. Collaboration with pharmacist, microbiologist and hospital
manager;
c. Active participation for clinical consulting;
d. Personal professional improvement;
e. Holding education and training in hospital about antibac-
terial rational use;
f. Conducting clinical and basic researches.
CS10-02 Antibiotic and Antifungal Resistance in
Antibiotic “Free” Environment
V. Krcmery*, E. Kalavsky. St. Elizabeth University College of
Health and Social Sciences, Laboratory of Tropical Diseases,
Slovakia
It is widely accepted that in community antibiotic/antifungal
resistance is related with consumption. One of the arguments
“pro” is reversibility of resistance which happens frequently in
hospital but was detected also in the community level in at least
3 countries (Denmark, Iceland and Finland).
As every rule is conﬁrmed by an exception, here are several
examples of antimicrobial resistance in regions with no or very
little antimicrobial pressure. We have observed and published
data on absence of resistance to penicillin, oxacillin and ery-
thromycin in S. pneumoniae and S. aureus in an area isolated 21
years by civil war in southern Sudan with no communication, no
health infrastructure and no antimicrobial drugs on the market
however among the same patients 80% tetracycline resistance in
viridans streptococci was observed.
We have observed 66-75% ceftazidim resistance in Enterobacter
spp. Isolated from Cambodian HIV positive children living in
rural areas where no antibiotic drugs are accessible. Last year
a report on high quinolone resistance in E. coli from indigenous
Indian population in rural Bolivia was published by Bartoloni et
al. Similar situation was observed among inhabitants of very
isolated villages from Amazon basin in Peru and Bolivia. Shahum
et al. described 8 children infected with voriconazol resistant
Candida spp. strains from rain forest rural area of Cambodia
near Viet Nam border. Those children and their parents never
received according to patient’s history and medication for years.
Other two similar observations are coming from Nepal and French
Guyana. Those at least 7 reports does no weak our conclusion
that consumption of antibiotics is a major driver of antimicrobial
resistance in the community. However ﬁndings from southern
Sudan, Cambodia, Peru and Bolivia indicate that other factors
promoting antimicrobial resistance in absence of antimicrobial
pressure should be studied as well.
CS10-03 Antibiotic Resistance and the Role of Antibiotic
Stewardship
Victor Lim*. International Medical University, Kuala Lumpur,
Malaysia
The discovery of antibiotics is one of the most signiﬁcant event
in medical history. Antibiotics have added a decade to the aver-
age life expectancy. Together with vaccination, clean water and
other public health measures, mortality from infectious diseases
was dramatically reduced. There was great optimism in the
1950s and 1960s that infectious diseases were no longer a major
challenge. Unfortunately this optimism was unfounded due to
various reasons including the emergence of antibiotic resistance.
Resistance is not new. Sir Alexander Fleming, the discoverer of
penicillin said in his Nobel Prize Address in 1945 that, “It is not
difﬁcult to make microbes resistant to penicillin in the laboratory
by exposing them to concentrations not sufﬁcient to kill them,
and the same thing has occasionally happened in the body.”
The resistome is the collection of all the antibiotic resis-
tance genes and their precursors both in pathogenic and non-
pathogenic bacteria. Studies of the soil resistome has revealed
antibiotic resistant genes to a wide variety of antibiotics in-
cluding synthetic compounds like quinolones and newer antimi-
crobials like Synercid and daptomycin despite no known prior
exposure to these antibiotics or their analogues. The develop-
ment of antimicrobial resistance had therefore been going on in
nature long before antibiotics came into medicinal use. A recent
study has also shown that bacteria can subsist on antibiotics as
their sole carbon source. The soil resistome therefore constitute
an unappreciated reservoir that can contribute to increasing
resistance in pathogenic bacteria
Antibiotic resistance is a major challenge world-wide. It occurs in
gram positive as well in gram negative organisms and in health-
care associated as well as in community acquired infections. In
the last two decades only 2 new classes of anti-bacterials (the
oxazolidinones and the lipopeptides) have been introduced for
clinical use. The situation is now so dire that some physicians
have predicted that there will not be any effective antibiotics to
treat seriously ill patients in the near future.
